Literature DB >> 3935775

Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery.

M Fujioka, H Kuriyama.   

Abstract

The effects of eperisone, an antispasmodic, on the electrical and mechanical properties of smooth muscle cells of the guinea-pig basilar artery were investigated. Eperisone (below 50 microM) did not modify the membrane potential, membrane resistance, excitatory junction potential evoked by perivascular nerve stimulation or the K- and 5-hydroxytryptamine-induced depolarizations. However, in concentrations over 10 microM, this agent reversibly blocked the spontaneously generated and evoked action potentials in the presence of 5 to 8 mM tetraethylammonium. The contractions evoked by high concentrations of K, 5-hydroxytryptamine or direct muscle stimulation in the presence of tetraethylammonium were dose dependently inhibited by eperisone, in concentrations over 1 microM. In Ca-free 2 mM ethylene glycol bis(beta-aminoethyl ether)-N,N'-tetraacetic acid-containing solution, 5-hydroxytryptamine produced only a single contraction. Eperisone inhibited this contraction to the same extent as that observed in the presence of Ca. These results indicate that eperisone possesses the property of a Ca antagonist on smooth muscle tissues of the guinea-pig basilar artery, in addition to the action of antispastic agent, i.e., this agent blocks the voltage-dependent influx of Ca at the smooth muscle membrane, but not at the nerve terminals, and inhibits the action of Ca in cells through inhibition of the contractile protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935775

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry.

Authors:  Barbara Melilli; Cateno Piazza; Daniela Cristina Vitale; Maria Rosa Marano; Andrea Pecori; Paolo Mattana; Valentina Li Volsi; Carmelo Iuculano; Francesco Cardì; Filippo Drago
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-03-30       Impact factor: 2.441

2.  Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial.

Authors:  Xuejiao Guo; Lin Li; Zhe Yan; Yunze Li; Zhiyou Peng; Yixin Yang; Yanfeng Zhang; Christoph Schmitz; Zhiying Feng
Journal:  J Orthop Surg Res       Date:  2021-12-04       Impact factor: 2.359

Review 3.  Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.

Authors:  Stefan Quasthoff; Claudia Möckel; Walter Zieglgänsberger; Wolfgang Schreibmayer
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

4.  Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs.

Authors:  Nicholas V Cozzi; Simon D Brandt; Paul F Daley; John S Partilla; Richard B Rothman; Andreas Tulzer; Harald H Sitte; Michael H Baumann
Journal:  Eur J Pharmacol       Date:  2012-11-21       Impact factor: 4.432

5.  Basic aspects of the pharmacodynamics of tolperisone, a widely applicable centrally acting muscle relaxant.

Authors:  Kornelia Tekes
Journal:  Open Med Chem J       Date:  2014-07-11

6.  Eperisone hydrochloride-induced maculopapular rash.

Authors:  Namrata Balaraddiyavar; Aruna Bhushan; Basavaraj C Kotinatot; Gouramma Huggi
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.